Phase I clinical and translational evaluation of AZD6738 in combination with durvalumab in patients (pts) with lung or head and neck carcinoma
Authors
Krebs, Matthew GLopez, J
El-Khoueiry, A
Bang, Y
Postel-Vinay, S
Abidah, W
Im, S
Khoja, L
Standifer, N
Jones, G
Marco-Casanova, P
Frewer, P
Berges, A
Cheung, A
Stephens, C
Felicetti, B
Dean, E
Pierce, A
Hollingsworth, S
Affiliation
Phase I Unit, The Christie NHS Foundation Trust, Manchester, UKIssue Date
2018
Metadata
Show full item recordCitation
Krebs M, Lopez J, El-Khoueiry A, Bang YJ, Postel-Vinay S, Abidah W, et al. 413PD Phase I clinical and translational evaluation of AZD6738 in combination with durvalumab in patients (pts) with lung or head and neck carcinoma. Ann Oncol. 2018;29(suppl_8):135.Journal
Annals of OncologyDOI
10.1093/annonc/mdy279.401Additional Links
https://dx.doi.org/10.1093/annonc/mdy279.401Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy279.401